118 results about "Pantoea" patented technology

A method of reducing the content of TSNA in tobacco leaves, comprising treating the tobacco leaves with a microorganism having no nitrate-reducing ability but having the ability of growth-competition with a microorganism belonging to Enterobacter or Pantoea genus.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to genus Escherichia or Pantoea, which has been modified to attenuate expression of a gene coding for sRNA.

The present invention provides a method for producing L-arginine using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to the genus Escherichia or Pantoea, which has been modified to attenuate expression of one or several genes encoding an L-arginine transporter.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to genus Escherichia or Pantoea, which has been modified to attenuate expression of a gene coding for sRNA.

The invention provides a complex flora for preventing and treating peanut root rot and an application thereof, and belongs to the technical field of soil-borne disease prevention and treatment. The complex flora comprises pantoea, pseudobacillus, enterobacter, paenibacillus, sporosarcina, bacillus and pseudomonas aeruginosa. The pantoea, the pseudobacillus, the enterobacter, the paenibacillus, thesporosarcina, the bacillus and the pseudomonas aeruginosa in the complex flora have a synergistic interaction effect on inhibition of pathogenic fungi; compared with a single strain, the complex flora has the advantages that the rhizosphere colonization capacity is obviously improved, and the rhizosphere micro-ecological environment can be effectively optimized. The complex flora is inoculated topeanut roots, so that the peanut roots can be effectively prevented from being infected by fusarium oxysporum, and the health of the peanut roots is protected.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to genus Escherichia or Pantoea, which has been modified to attenuate expression of a gene coding for sRNA.

The present invention belongs to the technical fields of agriculture and environmental pollution treatment, and relates to endophytic bacteria capable of producing ACCD, its soil renovation bacterium agent and an application thereof. The endophytic bacteria Jp3-3 which is named as Pantoea agglomerans Jp3-3 and preserved in the China Center for Type Culture Collection (CCTCC), the preservation date is 13th July, 2011, and the collection number of CCTCC is No: M 2011250. The ACCD enzymatic activity of the bacteria can reach as high as 402umM alpha-KB.h<-1>.mg<-1>; a liquid preparation contains effective live bacteria with amount of more than 1 billion / milliliter, a solid preparation contains live bacteria with amount of more than 0.2 billion / gram. The direct application of the soil renovation bacterium agent is capable of promoting the growth of the plants, absorbing the heavy metal and reinforcing the efficiency of plants for restoring the soil polluted by the heavy metal.

The invention discloses a pantoea agglomerans strain and application thereof. The pantoea agglomerans strain is named as Pantoea agglomerans ZJU23, with a preservation number of CGMCC No.16174 and a preservation date of July 30, 2018. According to the pantoea agglomerans strain, the control effect on wheat scab is up to 50-70%, vomitoxin is reduced by 50-80%, diseases caused by plant pathogenic fungi such as gibberellic disease, gray mold, rice blast, colletotrichum destructivum and rice sheath blight disease can also be simultaneously controlled, and the range of controlling is wide.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to the genus Escherichia or Pantoea, which has been modified to attenuate expression of the aldH gene.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to genus Escherichia or Pantoea, which has been modified to attenuate expression of the rspAB operon.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to genus Escherichia or Pantoea, which has been modified to have glycerol kinase in which feedback inhibition by fructose-1,6-bisphosphate is desensitized, thereby having enhanced ability to utilize glycerol.

The present invention aims at providing a vaccine composition capable of being administered to an intraoral mucous membrane, ocular mucous membrane, ear mucous membrane, genital mucous membrane, pharyngeal mucous membrane, respiratory tract mucous membrane, bronchial mucous membrane, pulmonary mucous membrane, gastric mucous membrane, enteric mucous membrane, or rectal mucous membrane, that is safe, useful as a prophylactic or therapeutic agent for infectious diseases or cancers, and capable of effectively inducing the systemic immune response and mucosal immune response. The present invention provides a mucosal vaccine composition to be administered to at least one mucous membrane selected from the group consisting of a human or animal intraoral mucous membrane, ocular mucous membrane, ear mucous membrane, genital mucous membrane, pharyngeal mucous membrane, respiratory tract mucous membrane, bronchial mucous membrane, pulmonary mucous membrane, gastric mucous membrane, enteric mucous membrane, and rectal mucous membrane, the mucosal vaccine composition containing: at least one antigen; and as an adjuvant, a lipopolysaccharide derived from at least one gram-negative bacterium selected from the group consisting of Serratia, Leclercia, Rahnella, Acidicaldus, Acidiphilium, Acidisphaera, Acidocella, Acidomonas, Asaia, Belnapia, Craurococcus, Gluconacetobacter, Gluconobacter, Kozakia, Leahibacter, Muricoccus, Neoasaia, Oleomonas, Paracraurococcus, Rhodopila, Roseococcus, Rubritepida, Saccharibacter, Stella, Swaminathania, Teichococcus, Zavarzinia, Pseudomonas, Achromobacter, Bacillus, Methanoculleus, Methanosarcina, Clostridium, Micrococcus, Flavobacterium, Pantoea, Acetobacter, Zymomonas, Xanthomonas, and Enterobacter, or a salt thereof, wherein a mass ratio between the adjuvant and the antigen (total mass of the adjuvant / total mass of the antigen) is 0.002 to 500.

The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging to genus Escherichia or Pantoea, which has been modified to attenuate expression of the rspAB operon.

An organic acid is produced by allowing a bacterium belonging to the family Enterobacteriaceae, which has an ability to produce an organic acid and has been modified so that the phosphoenolpyruvate carboxykinase activity is enhanced, which is selected from Enterobacter, Pantoea, Erwinia, Klebsiella and Raoultella bacteria, or a product obtained by processing the bacterium, to act on an organic raw material in a reaction mixture containing carbonate ions, bicarbonate ions, or carbon dioxide gas to produce the organic acid, and collecting the organic acid.

The invention discloses a microbial source combined biostimulant. The microbial source combined biostimulant is characterized by being prepared from the following components, by mass: 0.1 to 17.5 percent of polyglutamic acid, 0 to 5.0 percent of amino-oligosaccharin, 0.05 to 2.0 percent of pantoea polysaccharide, 0 to 1.5 percent of gamma-aminobutyric acid and the balance of auxiliary materials. The microbial source combined biostimulant can effectively improve the utilization rate of a plant fertilizer, improve the disease resistance and stress resistance of the plant fertilizer and induce aself-defense system of the plant fertilizer, can be completely biodegraded in soil, and is non-toxic, harmless and pollution-free to plants and the soil environment.

The invention relates to a Konjak endophytic bacteria Pantoea agglomerans bacterial strain1-7 and an application, which belongs to the biology technical field. The Pantoea agglomerans1-7 is preserved in the China General Microbiological Culture Collection Center on May 28th, 2012 with the preservation number of CGMCC No.6160. The Konjak endophytic bacteria Pantoea agglomerans bacterial strain1-7 is used for preparing the preparations used for preventing and treating bacterial soft rot of konjak and clubroot disease on cruciferous vegetable club root in fields. The Konjak endophytic bacteria Pantoea agglomerans bacterial strain1-7 has the advantages of high efficiency, no toxicity, safety and no residue, the bacterial strain1-7 has the characteristics of good disease control, better growth promotion effect, better comprehensive characters and easy industrial production, and the Pantoea agglomerans1-7 can be applied to preparation of preparations for controlling cruciferous vegetable club root in fields.